Cellegy Pharmaceuticals has received an approvable letter from the US FDA for its nitroglycerin ointment [Cellegesic] for anal fissures.

Source: Inpharma, Volume 1, Number 1546, 2006-07-15 , pp. 23-23(1)

Publisher: Adis International

Keywords: Cellegy-Pharmaceuticals; Development-status; Nitroglycerin, therapeutic use; Pain, treatment

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers